Nasopharyngeal Carcinoma Treatment Market, By Drug (Ellence, Taxotere, Bleomycin, and Methotrexate), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook and Opportunity Analysis 2018–2026

  • To Be Published : Dec 2018 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Nasopharyngeal carcinoma is a rare cancer, affecting the part of throat connecting nose and mouth, known as pharynx. Nasopharyngeal carcinoma are of three types, based on cell appearance under microscope. These include keratinizing squamous cell carcinoma, non- keratinizing differentiated carcinoma, and undifferentiated carcinoma. The early stage symptoms of nasopharyngeal carcinoma are bleeding nose, blockage and stuffiness in nose, persistent ear infection, hearing difficulties, and sore throat whereas, late stage symptoms includes weight loss, facial pain, and bulging eye.

Nasopharyngeal cancers are diagnosed by EBV antibody test, X-ray, ultrasound, endoscopy, biopsy, CT scan, MRI, PET scan or PET-CT scan. Nasopharyngeal treatment includes use of radiation therapy or chemotherapy, however, surgery is done in very rare cases. According to National Center for Biotechnology Information 2016, incidence of nasopharyngeal cancer differs according to the geography, where 81% of new cases are observed in Asia, 9% in Africa and only 10% are diagnosed in rest of the world. Nasopharyngeal carcinoma treatment market is expected to be driven by high incidence rate of the cancer in Asian countries and increasing research and development studies by research organization and universities for treatment of this cancer.

Nasopharyngeal Carcinoma Treatment Market – Driver

Increasing incidence of nasopharyngeal cancer is expected to drive growth of the nasopharyngeal carcinoma treatment market in the forecast period (2018-2026. According to American Cancer Society, 2016, incidence of nasopharyngeal cancer is 1 in 100,000 each year, globally. Furthermore, it estimates that as of 2015, there would be about 3,200 cases of nasopharyngeal cancer in the U.S. According to Canadian Cancer Society’s statistics 2013, 240 Canadians are diagnosed with nasopharyngeal cancer every year whereas, 102 die due to nasopharyngeal cancer every year. According to NHS UK, in the U.K., about 240 people are diagnosed with nasopharyngeal cancer each year.

Furthermore, according to the World Cancer Research 2018, nasopharyngeal cancer is about three times more common in men as compared to women. According to article in Chinese Journal of Cancer, 21,320 people died due to nasopharyngeal cancer in China in 2013, which attributes to 1.14% of all new cancer cases and 0.96% of all cancer-related deaths. Moreover, increasing exposure to smoking tobacco, Epstein-Barr virus, wood dust, and others is expected to further propel growth of the nasopharyngeal cancer and in turn its treatment market.

Research studies conducted by researchers and healthcare providers, to develop better treatment option, is further expected to propel growth of the nasopharyngeal carcinoma treatment market. Taiho Pharmaceutical has new chemotherapy drugs such as S-1 and valproic acid which shows promising potential to treat head and neck cancer.

On other hand, popularity of targeted therapies such as tyrosine kinase inhibitors (dacomitinib, gefitinib, afatinib, erlotinib and lapatinib), phosphoinositide 3-kinase inhibitors (PX-866 and buparlisib), monoclonal antibodies (panitumumab), and mTOR inhibitors (everolimus and temsirolimus) is increasing significantly for the treatment of cancers. For instance, Cetuximab also known as Erbitux, a monoclonal antibody that acts as epidermal growth factor receptor (EGFR) inhibitor, is been in trial for treating squamous cell nasopharyngeal cancer. Furthermore, nimotuzumab is another EGFR inhibitor with chemotherapy to treat locally advanced nasopharyngeal cancer.

Moreover, antitumor activity of nivolumab (Opdivo) is evaluated for recurrent and metastatic nasopharyngeal carcinoma by Mayo Clinic, which was in phase II clinical trials as per article published in Journal of Clinical Oncology, March 2018.

Nasopharyngeal Carcinoma Treatment Market - Regional Analysis

Geographically, the nasopharyngeal carcinoma treatment market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America is expected to be dominant market over the forecast period, owing to increasing research and developmental activities by key market players in the region to develop better treatment.

However, Asia Pacific is expected to be fastest growing hypo-pharyngeal cancer treatment market, due to increasing incidence of nasopharyngeal carcinoma in the region. According to Canadian Cancer Society, the risk factor for developing cancer is higher in Southeast Asian or Chinese ancestry, particularly Cantonese ancestry. According to Union for International Cancer Control 2014, APAC countries like Southern China and Southeast Asia, the annual age-standardized incidence rates are as high as 20 to 30 cases per 100,000 population in men and 8 to 15 cases per 100,000 populations in women in comparison to U.S. which is less than 1 per 100,000. Moreover, according to article published in World Cancer Research Journal, in 2012, there were 42,100 cases of nasopharyngeal cancer detected in China, 13,084 cases in Indonesia, 4,931 cases in Vietnam, 3,947 in India, and 2,030 in Malaysia.

Nasopharyngeal Carcinoma Treatment Market – Competitors

Key players operating in the global nasopharyngeal carcinoma treatment market are Pfizer Inc., Sanofi, Merck & Co., Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., and Fresenius SE & Co. KGaA.

Nasopharyngeal Carcinoma Treatment Market - Taxonomy

By Drug

  • Ellence
  • Taxotere
  • Bleomycin
  • Methotrexate

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.